Skip to main content

Table 4 Impacts of diverse delayed extents on overall survival and disease relapses

From: Risk factors and negative consequences of patient’s delay for penile carcinoma

Variables

Overall survival, year (≥2 vs. <2)

Overall survival, year (≥5 vs. <5)

 

Relapses within 2 yearsa (none vs. relapsesb)

Relapses within 5 yearsa (none vs. relapsesb)

OR (95 % CI)

p value

OR (95 % CI)

p value

 

OR (95 % CI)

p value

OR (95 % CI)

p value

Undelayed (n = 63)

Reference

 

Reference

 

Undelayed (n = 63)

Reference

 

Reference

 

Delay 1–3 months (n = 64)

0.984 (0.134–7.209)

1.000e

1.309 (0.456–3.762)

0.616

Delay 1–3 months (n = 62)

0.803 (0.307–2.097)

0.653

0.870 (0.395–1.914)

0.728

Delay 3–6 months (n = 46)

2.905 (0.509–16.587)

0.238e

1.684 (0.564–5.034)

0.347

Delay 3–6 months (n = 46)

0.709 (0.242–2.081)

0.530

0.694 (0.286–1.689)

0.420

Delay >6 months (n = 55)

5.191 (1.053–25.598)

0.043e

2.476 (0.909–6.746)

0.070

Delay >6 months (n = 54)

0.945 (0.359–2.487)

0.909

0.714 (0.307–1.659)

0.433

  1. OR odds ratios, CI confidence intervals
  2. aAfter radical therapies
  3. bRelapses includes local, regional, and distant recurrences, and new primary lesions are classified into local recurrence
  4. eFisher exact test